ATM and HIV infectious disease: To test this hypothesis, cultured CD4 T cells with TCR activation were infected with HIV in the presence of DMSO or ATM inhibitor (ATMi, 10 μM KU60019) for 3, 5, and 7 days, followed by measuring the levels of T cell early activation marker CD25, HIV infection marker p24, and DNA damage marker γH2AX.